je.st
news
Tag: pfizer
Merck KGaA, Darmstadt, Germany, And Pfizer Announce FDA Orphan Drug Designation For Investigational Immunotherapy Avelumab In Merkel Cell Carcinoma
2015-09-30 08:25:02| drugdiscoveryonline News Articles
Merck KGaA, Darmstadt, Germany, and Pfizer recently announced that the US Food and Drug Administration (FDA) has granted orphan drug designation for the investigational cancer immunotherapy avelumab* for the treatment of Merkel cell carcinoma (MCC), a rare and aggressive type of skin cancer
Tags: germany
cell
drug
announce
Merck and Pfizer Collaborate with Dako, an Agilent Technologies...
2015-09-25 14:54:44| Biotech - Topix.net
As part of the global strategic alliance between Merck and Pfizer to jointly develop and commercialize avelumab*, an investigational immune checkpoint inhibitor, the companies have announced that they have a collaboration agreement in place with Dako, an Agilent Technologies company, for the development of a potential companion diagnostic test . The three-party agreement, signed recently, enables Dako, Merck and Pfizer to work to develop the CDx to assess programmed death-ligand 1 protein expression levels in tumor tissue, and its microenvironment, including tumor-associated immune cells.
Tags: technologies
collaborate
merck
pfizer
Pfizer says it could be leader in cancer with many new drugs
2015-09-22 20:12:21| Biotech - Topix.net
Drug giant Pfizer is starting 20 clinical trials this year and more soon after on treatments to conquer cancer as it also seeks to gain leadership in one of the hottest, and most lucrative, areas of medicine. A decade ago, the world's second-biggest drugmaker by revenue wasn't even a player in cancer medicine.
Bristol-Myers Squibb and Pfizer to Present New Data on Eliquis (apixaban) at the ESC Congress 2015
2015-08-24 22:52:31| Biotech - Topix.net
Bristol-Myers Squibb Company and Pfizer Inc. announced today that 22 abstracts will be presented at the Congress 2015, to be held August 29 to September 2 in London, United Kingdom. The new data reinforce the Alliance's commitment to the ongoing evaluation of Eliquis in both the nonvalvular atrial fibrillation and venous thromboembolism patient populations.
Tags: the
data
present
congress
Pfizer says Hospira purchase will close in early September
2015-08-24 18:23:10| Biotech - Topix.net
Drugmaker Pfizer says it's received the final regulatory approvals for its $15.23 billion purchase of the injectable drug and infusion device maker Hospira, and says the deal will close in early September. The New York company said Monday regulators in the U.S. and Brazil cleared the deal.
Tags: september
close
purchase
early
Sites : [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] next »